fluorouracil has been researched along with fluorescein in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Huang, M; Jin, J; Liu, GT; Wei, HL | 1 |
He, B; Lee, SB; Reichel, J; Schuchman, M; Son, SJ | 1 |
Chen, H; Gu, Y; Hu, Y | 1 |
Gülden, O; Wiedmann, TS | 1 |
Cui, X; Gao, M; Liu, S; Liu, Y; Qu, Y; Wang, C; Xu, J; Yang, Y | 1 |
5 other study(ies) available for fluorouracil and fluorescein
Article | Year |
---|---|
Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).
Topics: Buthionine Sulfoximine; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Fluorescein; Fluorouracil; Glutathione; Glutathione Transferase; Humans; Liver Neoplasms; Multidrug Resistance-Associated Proteins; Thymidylate Synthase; Tumor Cells, Cultured | 2002 |
Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery.
Topics: Animals; Antigen-Antibody Reactions; Drug Delivery Systems; Ferrosoferric Oxide; Fluorescein; Fluorouracil; Humans; Ibuprofen; Immunoglobulin G; Iron; Magnetics; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanotubes; Nitrophenols; Oxides; Serum Albumin, Bovine; Silicon Dioxide | 2005 |
Comparison of two polymeric carrier formulations for controlled release of hydrophilic and hydrophobic drugs.
Topics: Acrylamides; Acrylic Resins; Angiogenesis Inhibitors; Antimetabolites; Drug Carriers; Fluorescein; Fluorouracil; Nanoparticles; Particle Size; Polymers; Temperature; Thalidomide; Time Factors | 2008 |
Deposition of aerosol particles in a model vitreous chamber.
Topics: Administration, Ophthalmic; Aerosols; Cesium; Chemistry, Pharmaceutical; Chlorides; Drug Delivery Systems; Fluorescein; Fluorouracil; Particle Size; Retinal Diseases; Time Factors; Tissue Distribution; Vitrectomy; Vitreous Body | 2012 |
Dissolvable microneedles based on Panax notoginseng polysaccharide for transdermal drug delivery and skin dendritic cell activation.
Topics: Administration, Cutaneous; Animals; B7-1 Antigen; B7-2 Antigen; CD40 Antigens; Compressive Strength; Doxorubicin; Fluorescein; Fluorouracil; Langerhans Cells; Male; Mice; Myosin Heavy Chains; Needles; Panax notoginseng; Polysaccharides; Rats, Sprague-Dawley; Skin; Solubility | 2021 |